Obstetric and newborn outcomes in a cohort of HIV-infected pregnant women: A report of the women and infants transmission study

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 20, Issue 2, 1999, Pages 179-186

  Stratton, Pamela ^a   Tuomala, Ruth E ^b   Abboud, Rasha ^c   Rodriguez, Evelyn ^d   Rich, Kenneth ^e   Pitt, Jane ^f   Diaz, Clemente ^g   Hammill, Hunter ^h   Minkoff, Howard ⁱ  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c NEW ENGLAND RESEARCH INSTITUTES   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f Univ of Puerto Rico Sch of Med ^*  (United States)

^g UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

ⁱ SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

HIV infection in pregnancy; Newborn and pregnancy outcomes

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FETUS OUTCOME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MATERNAL DISEASE; MOTHER CHILD RELATION; NEWBORN; PRIORITY JOURNAL; RISK ASSESSMENT; VIRUS TRANSMISSION;

EID: 0033081272     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199902010-00011     Document Type: Article

References (46)

1. Minkoff H, Nanda D, Menez R, Fikrig S. Pregnancies resulting in infants with acquired immunodeficiency syndrome or AIDS-related complex. Obstet Gynecol 1987;69:285-7.
2. Gloeb DJ, O Sullivan MJ, Efantis J. Human immunodeficiency virus infection in women. The effects of human immunodeficiency virus on pregnancy. Am J Obstet Gynecol 1988;159:756-61.
3. Temmerman M, Chomba EN, Ndinya-Achola J, Plummer FA, Coppens M, Piot P. Maternal human immunodeficiency virus-1 infection and pregnancy outcome. Obstet Gynecol 1994;83:495-501.
4. Braddick MR, Kreiss JK, Embree JE, et al. Impact of maternal HIV infection on obstetrical and early neonatal outcome. AIDS 1990; 4:1001-5.
5. Selwyn PA, Schoenbaum EE, Davenny K, et al. Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users. JAMA 1989;261:1289-94.
6. Alger LS, Farley JJ, Robinson BA, Hines SE, Berchin JM, Johnson JP. Interactions of human immunodeficiency virus infection and pregnancy. Obstet Gynecol 1993;82:787-96.
7. Minkoff HL, Henderson C, Mendez H, et al. Pregnancy outcomes among mothers infected with human immunodeficiency virus and uninfected control subjects. Am J Obstet Gynecol 1990;163:1598-1604.
8. Moye J, Rich KC, Kalish LA, et al. Natural history of somatic growth in infants born to women infected by human immunodeficiency virus. Women and Infants Transmission Study Group. J Pediatr 1996;128:58-69.
9. Rodriguez EM, Mofenson LM, Chang BH, et al. Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission. AIDS 1996;10:273-82.
10. Landesman SH, Kalish LA, Burns DN, et al. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study. N Engl J Med 1996;334:1617-23.
11. Sheon AR, Fox HE, Rich KC, et al. The women and infants transmission study (WITS) of maternal-infant HIV transmission: study design, methods, and baseline data. J Womens Health 1996;5:69-78.
12. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Micmbiol 1991;29:297-301.
13. Calvelli T, Denny TN, Paxton H, Gelman R, Kagan J. Guideline for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry 1993;14:702-15.
14. Kidd PG, Cheng S-C, Paxton H, Landay A, Gelman R. Prediction of CD4 Count from CD4 percentage: experience from three laboratories. AIDS 1993;7:933-40.
15. + lymphocytes during pregnancy and 1 year postpartum in human immunodeficiency virus-infected women. The Women and Infants Transmission Study. Obstet Gynecol 1997;89:967-74.
16. Hollinger FB, Bremer JW, Myers LE, Gold JWM, McQuay L, and the NIH/NIAID/DAIDS/ACTG Virology Laboratories: standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS clinical trials group. J Clin Microbiol 1992;30: 1787-94.
17. Brazie JV, Lubchenco LO. The estimation of gestational age chart, in Kempe, Silver and O Brien. Current Pediatric Diagnosis and Treatment, ed 3. Los Altos, CA: Lange Medical Publications, 1974.
18. Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M. A United States National Reference for Fetal Growth. Obstet Gynecol 1996;87:163-8.
19. Rawlings JS, Rawlings VB, Read JA. Prevalence of low birth weight and preterm delivery in relation to the interval between pregnancies among white and black women. N Engl J Med 1995; 332:69-74.
20. Agresti A. Categorical data analysis. New York: John Wiley & Sons, 1990.
21. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons, 1990.
22. SAS Institute. SAS/STAT user's guide, version 6, 4th ed, vols 1 and 2. Cary, NC: SAS Institute Inc., 1990.
23. Kumar RM, Udaman SA, Khurranna AK. Impact of maternal HIV-I infection on perinatal outcome. Int J Gynaecol Obstet 1995; 49:137-13.
24. Turner BJ, McKee LJ, Silverman NS, Hauck WW, Fannigan TR, Markson LE. Prenatal care and birth outcomes of a cohort of HIV-infected women. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12:259-67.
25. Bulterys M, Chao A, Munyemanas, et al. Maternal human immunodeficiency virus 1 infection and intrauterine growth: a prospective cohort study in Butare, Rwanda. Pediatr Infect Dis J 1994; 13:94-100.
26. Chamiso D. Pregnancy outcome in HIV-1 positive women in Gandhi Memorial Hospital Addis Ababa, Ethiopia. East Afr Med J 1996;73:805-9.
27. Centers for Disease Control and Prevention. HIV-AlDS surveillance report 1995;7(no.2):1-39.
28. Zuckerman B, Frank D, Hingson R, et al. Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med 1989; 320:762-8.
29. Council on Ethical and Judicial Affairs. Black-white disparities in health care. JAMA 1990;263:2344-6.
30. Kleinman JC, Kessel SS. Racial differences in low birth weight. N Engl J Med 1987;317:749-53.
31. Shiono PH, Klebanoff MA. Ethnic differences in preterm and very preterm delivery. Am J Public Health 1986;76:1317-21.
32. Centers for Disease Control and Prevention/National Center for Health Statistics. Advance Report of Final Natality Statistics, 1994. Monthly Vital Statistics Report 1996;44:1-86.
33. Adams MM, Read JA, Rawlings JS, Harlass FB, Sarno AP, Rhodes PH. Preterm delivery among black and white enlisted women in the United States Army. Obstet Gynecol 1993:81:65-71.
34. Schwartz IL. Low birthweight effects of demographic and socioeconomic variables and prenatal care in Pima County, Arizona. West J Med 1990;152:725-8.
35. Sprauve ME, Lindsay MK, Herbert S, Graves W. Adverse perinatal outcome in parturients who use crack cocaine. Obstet Gynecol 1997;89:674-8.
36. Goldfarb NI, Hillman AL, Eisenberg JM, Kelley MA, Cohen AV, Dellheim M. Impact of a mandatory Medicaid case management program on prenatal care and birth outcomes: a retrospective analysis. Med Care 1991;29:64-71.
37. Nair P, Alger L, Hines S, Seiden S, Hebel R, Johnson JP. Maternal and neonatal characteristics associated with HIV infection in infants of seropositive women. J Acquir Immune Defic Syndr 1993; 6:298-302.
38. Gabiano C, Tovo PA, deMartino M, et al. Mother to child transmission of human immunodeficiency virus type 1 : risk of infection and correlates of transmission. Pediatrics 1992;90:369-74.
39. Mofenson LM. Epidemiology and determinants of vertical HIV transmission. Semin Pediatr Infect Dis 1994;5:252-5.
40. McGregor JA, French JI, Parker R, et al. Prevention of premature birth by screening and treatment for common genital tract infections: results of a prospective controlled evaluation. Am J Obstet Gynecol 1995;173:157-67.
41. Williams MA, Mittendorf R, Lieberman E, Monson RR. Adverse infant outcomes associated with first trimester vaginal bleeding. Obstet Gynecol 1991;78:14-8.
42. Sipila P, Hartikainen-Sorri AL, Oja H, Von Wendt L. Perinatal outcome of pregnancies complicated by vaginal bleeding. Br J Obstet Gynecol 1992;99:959-63.
43. Harger JH, Hsing AW, Tuomala RE, et al. Risk factors for preterm premature rupture of fetal membranes: a multicenter case-control study. Am J Obstet Gynecol 1990;163:130-7
44. Gibbs RS, Romero R, Hillier SL, Eschenbach DA, Sweet RL. A review of premature birth and subclinical infection. Am J Obstet Gynecol 1992;166:1515-28.
45. Rodriguez EM, Vermund SH. Maternal drug use and pediatric HIV infection: a methodologic review. Pediatr AIDS HIV Infect Fetus Adolesc 1991:2:107-22.
46. McCalla S, Minkoff HL, Feldman J, Gloss L. Predictors of cocaine use in pregnancy. Obstet Gynecol 1991;79:641-4.